loadpatents
name:-0.049400091171265
name:-0.035547018051147
name:-0.0099568367004395
ARNOLD; Lee D. Patent Filings

ARNOLD; Lee D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ARNOLD; Lee D..The latest application filed is for "pharmaceutical compositions for the treatment of hbv".

Company Profile
9.36.39
  • ARNOLD; Lee D. - Mount Sinai NY
  • Arnold; Lee D. - Rancho Santa Fe CA
  • Arnold; Lee D. - Bloomington IN
  • Arnold; Lee D. - San Diego CA
  • Arnold; Lee D. - Mt. Sinai NY US
  • Arnold; Lee D. - East Islip NY US
  • Arnold; Lee D. - Farmingdale NY
  • Arnold; Lee D. - Niantic CT
  • Arnold; Lee D. - Westborough MA
  • Arnold; Lee D. - Westboro MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Compositions For The Treatment Of Hbv
App 20220241208 - ARNOLD; Lee D. ;   et al.
2022-08-04
Inhibitors of cyclin-dependent kinases
Grant 11,390,618 - Kanouni , et al. July 19, 2
2022-07-19
Inhibitors of cyclin-dependent kinases
Grant 11,358,958 - Kanouni , et al. June 14, 2
2022-06-14
Inhibitors of fibroblast growth factor receptor kinases
Grant 11,345,681 - Kaldor , et al. May 31, 2
2022-05-31
Inhibitors Of Cysteine Proteases And Methods Of Use Thereof
App 20220162194 - Arnold; Lee D. ;   et al.
2022-05-26
Inhibitors of cysteine proteases and methods of use thereof
Grant 11,312,704 - Arnold , et al. April 26, 2
2022-04-26
Hepatitis B Core Protein Modulators
App 20220023311 - Turner; William W. ;   et al.
2022-01-27
Process For Making Hepatitis B Core Protein Modulators
App 20210380577 - Li; Leping ;   et al.
2021-12-09
Inhibitors Of Cysteine Proteases And Methods Of Use Thereof
App 20210355111 - Arnold; Lee D. ;   et al.
2021-11-18
Inhibitors of cysteine proteases and methods of use thereof
Grant 11,174,231 - Arnold , et al. November 16, 2
2021-11-16
Inhibitors of cysteine proteases and methods of use thereof
Grant 11,124,497 - Arnold , et al. September 21, 2
2021-09-21
Cyclic sulfamide compounds and methods of using same
Grant 11,078,170 - Turner, Jr. , et al. August 3, 2
2021-08-03
Process for making Hepatitis B core protein modulators
Grant 11,040,965 - Li , et al. June 22, 2
2021-06-22
Process for making Hepatitis B core protein modulators
Grant 11,008,315 - Li , et al. May 18, 2
2021-05-18
Inhibitors Of Cyclin-dependent Kinases
App 20210130340 - KANOUNI; Toufike ;   et al.
2021-05-06
Hepatitis B core protein modulators
Grant 10,987,360 - Turner, Jr. , et al. April 27, 2
2021-04-27
Hepatitis B core protein modulators
Grant 10,968,211 - Turner, Jr. , et al. April 6, 2
2021-04-06
Inhibitors of cyclin-dependent kinases
Grant 10,894,788 - Kanouni , et al. January 19, 2
2021-01-19
Cyclic Sulfamide Compounds And Methods Of Using Same
App 20200157070 - Turner, JR.; William W. ;   et al.
2020-05-21
Hepatitis B Core Protein Modulators
App 20200131168 - Turner, JR.; William W. ;   et al.
2020-04-30
Inhibitors Of Cyclin-dependent Kinases
App 20200024266 - KANOUNI; Toufike ;   et al.
2020-01-23
Process For Making Hepatitis B Core Protein Modulators
App 20200002325 - Li; Leping ;   et al.
2020-01-02
Hepatitis B Core Protein Modulators
App 20190255067 - Turner, JR.; William W. ;   et al.
2019-08-22
Fused bicyclic mTOR inhibitors
Grant 8,796,455 - Chen , et al. August 5, 2
2014-08-05
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
Grant 8,735,405 - Arnold , et al. May 27, 2
2014-05-27
Combination cancer therapy
Grant 8,575,164 - Arnold , et al. November 5, 2
2013-11-05
FUSED BICYCLIC mTOR INHIBITORS
App 20130165651 - Chen; Xin ;   et al.
2013-06-27
Fused bicyclic motor inhibitors
Grant 8,314,111 - Chen , et al. November 20, 2
2012-11-20
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
App 20120196847 - Arnold; Lee D. ;   et al.
2012-08-02
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
App 20120077979 - Arnold; Lee D. ;   et al.
2012-03-29
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
Grant 8,101,613 - Arnold , et al. January 24, 2
2012-01-24
Fused Bicyclic mTOR Inhibitors
App 20110218183 - Chen; Xin ;   et al.
2011-09-08
FUSED BICYCLIC mTOR INHIBITORS
App 20110190496 - Chen; Xin ;   et al.
2011-08-04
Fused bicyclic mTOR inhibitors
Grant 7,943,767 - Chen , et al. May 17, 2
2011-05-17
Fused bicyclic mTor inhibitors
Grant 7,923,555 - Chen , et al. April 12, 2
2011-04-12
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
Grant 7,820,662 - Arnold , et al. October 26, 2
2010-10-26
FUSED BICYCLIC mTOR INHIBITORS
App 20100099679 - Chen; Xin ;   et al.
2010-04-22
Fused bicyclic mTOR inhibitors
Grant 7,700,594 - Chen , et al. April 20, 2
2010-04-20
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
App 20090325928 - Arnold; Lee D. ;   et al.
2009-12-31
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
Grant 7,560,552 - Michaelides , et al. July 14, 2
2009-07-14
Fused Bicyclic mTor Inhibitors
App 20090163468 - Chen; Xin ;   et al.
2009-06-25
6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors
Grant 7,534,797 - Arnold , et al. May 19, 2
2009-05-19
6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
App 20090118499 - Arnold; Lee D. ;   et al.
2009-05-07
Tricyclic pyrazole kinase inhibitors
Grant 7,468,371 - Arnold , et al. December 23, 2
2008-12-23
Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
App 20080299113 - Arnold; Lee D. ;   et al.
2008-12-04
Combination cancer therapy
App 20080267957 - Arnold; Lee D. ;   et al.
2008-10-30
Method of identifying inhibitors of Tie-2
Grant 7,369,946 - Bump , et al. May 6, 2
2008-05-06
Pyrazolopyrimidines as therapeutic agents
Grant 7,332,497 - Hirst , et al. February 19, 2
2008-02-19
Combined treatment with 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
App 20080014200 - Arnold; Lee D. ;   et al.
2008-01-17
N-phenylbenzotriazolyl c-kit inhibitors
App 20070232669 - Crew; Andrew Philip ;   et al.
2007-10-04
Fused heterobicyclic kinase inhibitors
App 20070208053 - Arnold; Lee D. ;   et al.
2007-09-06
Fused bicyclic mTOR inhibitors
App 20070112005 - Chen; Xin ;   et al.
2007-05-17
Thiopyrimidine and isothiazolopyrimidine Kinase Inhibitors
App 20060276490 - Michaelides; Michael R. ;   et al.
2006-12-07
6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors
App 20060235031 - Arnold; Lee D. ;   et al.
2006-10-19
Benzothiazole derivatives
Grant 7,091,227 - Scott , et al. August 15, 2
2006-08-15
Aminobenzoxazoles as therapeutic agents
App 20060025383 - Wishart; Neil ;   et al.
2006-02-02
Tricyclic pyrazole kinase inhibitors
App 20060014816 - Arnold; Lee D. ;   et al.
2006-01-19
Pyrazolopyrimidines as therapeutic agents
Grant 6,921,763 - Hirst , et al. July 26, 2
2005-07-26
Pyrrolopyrimidines as therapeutic agents
Grant 6,713,474 - Hirst , et al. March 30, 2
2004-03-30
Pyrazolopyrimidines as therapeutic agents
App 20040006083 - Hirst, Gavin C. ;   et al.
2004-01-08
Pyrazolopyrimidines as therapeutic agents
Grant 6,660,744 - Hirst , et al. December 9, 2
2003-12-09
Kinase inhibitors
App 20030225098 - Hirst, Gavin C. ;   et al.
2003-12-04
Kinase inhibitors
App 20030199525 - Hirst, Gavin C. ;   et al.
2003-10-23
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
App 20030181468 - Michaelides, Michael R. ;   et al.
2003-09-25
Pyrrolopyrimidines as therapeutic agents
App 20030153752 - Hirst, Gavin C. ;   et al.
2003-08-14
Benzothiazole derivatives
App 20030153568 - Cusack, Kevin P. ;   et al.
2003-08-14
Method of identifying inhibitors of Tie-2
App 20030082622 - Bump, Nancy J. ;   et al.
2003-05-01
Pyrazolopyrimidines as therapeutic agents
App 20020156081 - Hirst, Gavin C. ;   et al.
2002-10-24
Tricyclic pyrazole derivatives
Grant 6,462,036 - Doyle , et al. October 8, 2
2002-10-08
4-aminoquinazolone derivatives
Grant 6,225,318 - Sobolov-Jaynes , et al. May 1, 2
2001-05-01
4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents
Grant 5,736,534 - Arnold April 7, 1
1998-04-07
Company Registrations
SEC0001613258Arnold Lee D

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed